Home » Topics » BioWorld Science

BioWorld Science
RSS

AutoImmune's MS therapeutic in final stages of development

Nov. 15, 1996

Rx for Parkinson's disease from NeuroSearch/BMS enters phase II

Nov. 15, 1996

Latest findings on the diagnosis and treatment of erectile dysfunction

Nov. 15, 1996

Amrad product pipeline in review

Nov. 15, 1996

New company formed to discover novel cancer treatments

Nov. 15, 1996

Gensia announces strategic combination to form new pharmaceutical company

Nov. 15, 1996

Hitachi acquires U.S. biotech company

Nov. 15, 1996

U.S. patents and suits related to transgenic mice producing human antibodies

Nov. 15, 1996

Patent covers Advanced Magnetics' targeted drug delivery system

Nov. 15, 1996

Alanex and Aurora join forces to identify new lead compounds

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...